Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS
Clinical trial NCT04374149 · COMPLETED
Trial details
- NCT number
- NCT04374149
- Sponsor
- Prisma Health-Upstate
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2020-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.